211 related articles for article (PubMed ID: 29367729)
1. Ethanolic extract of the fungus Trichoderma stromaticum decreases inflammation and ameliorates experimental cerebral malaria in C57BL/6 mice.
Cariaco Y; Lima WR; Sousa R; Nascimento LAC; Briceño MP; Fotoran WL; Wunderlich G; Dos Santos JL; Silva NM
Sci Rep; 2018 Jan; 8(1):1547. PubMed ID: 29367729
[TBL] [Abstract][Full Text] [Related]
2. Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria.
Pontes KAO; Silva LS; Santos EC; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129813. PubMed ID: 33321150
[TBL] [Abstract][Full Text] [Related]
3. Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties.
Camara A; Haddad M; Reybier K; Traoré MS; Baldé MA; Royo J; Baldé AO; Batigne P; Haidara M; Baldé ES; Coste A; Baldé AM; Aubouy A
Malar J; 2019 Dec; 18(1):431. PubMed ID: 31852507
[TBL] [Abstract][Full Text] [Related]
4. Azadirachta indica ethanolic extract protects neurons from apoptosis and mitigates brain swelling in experimental cerebral malaria.
Bedri S; Khalil EA; Khalid SA; Alzohairy MA; Mohieldein A; Aldebasi YH; Seke Etet PF; Farahna M
Malar J; 2013 Aug; 12():298. PubMed ID: 23984986
[TBL] [Abstract][Full Text] [Related]
5. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
6. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
[TBL] [Abstract][Full Text] [Related]
7. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM
Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818
[TBL] [Abstract][Full Text] [Related]
8. Effect of mushroom Agaricus blazei on immune response and development of experimental cerebral malaria.
Val CH; Brant F; Miranda AS; Rodrigues FG; Oliveira BC; Santos EA; Assis DR; Esper L; Silva BC; Rachid MA; Tanowitz HB; Teixeira AL; Teixeira MM; Régis WC; Machado FS
Malar J; 2015 Aug; 14():311. PubMed ID: 26260055
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
[TBL] [Abstract][Full Text] [Related]
10. Rocaglates as dual-targeting agents for experimental cerebral malaria.
Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria.
Plirat W; Chaniad P; Phuwajaroanpong A; Konyanee A; Viriyavejakul P; Septama AW; Punsawad C
BMC Complement Med Ther; 2023 Sep; 23(1):332. PubMed ID: 37730604
[TBL] [Abstract][Full Text] [Related]
12. Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.
Francischetti IM; Oliveira CJ; Ostera GR; Yager SB; Debierre-Grockiego F; Carregaro V; Jaramillo-Gutierrez G; Hume JC; Jiang L; Moretz SE; Lin CK; Ribeiro JM; Long CA; Vickers BK; Schwarz RT; Seydel KB; Iacobelli M; Ackerman HC; Srinivasan P; Gomes RB; Wang X; Monteiro RQ; Kotsyfakis M; Sá-Nunes A; Waisberg M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):786-98. PubMed ID: 22116094
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q10 exhibits anti-inflammatory and immune-modulatory thereby decelerating the occurrence of experimental cerebral malaria.
Nyariki JN; Kimani NM; Kibet PS; Kinuthia GK; Isaac AO
Mol Biochem Parasitol; 2023 Sep; 255():111579. PubMed ID: 37385350
[TBL] [Abstract][Full Text] [Related]
14.
Elphinstone RE; Besla R; Shikatani EA; Lu Z; Hausladen A; Davies M; Robbins CS; Husain M; Stamler JS; Kain KC
Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28674030
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model.
Souraud JB; Briolant S; Dormoi J; Mosnier J; Savini H; Baret E; Amalvict R; Soulard R; Rogier C; Pradines B
Malar J; 2012 Jan; 11():13. PubMed ID: 22233563
[TBL] [Abstract][Full Text] [Related]
16. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
17. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
18. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.
Campos AC; Brant F; Miranda AS; Machado FS; Teixeira AL
Neuroscience; 2015 Mar; 289():166-80. PubMed ID: 25595981
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
